First and foremost, the goal is to keep people out of hospitals. The good news is all of the currently approved vaccines do just that.
Russian COVID-19 vaccine shows 91.6% efficacy in phase 3 trial
Russia’s Sputnik V coronavirus vaccine gives around 92% protection against COVID-19, results published in The Lancet reveal.
Vaccinating the most vulnerable first may not have the greatest impact on COVID-19, new model suggests
A new simulator can accurately model COVID-19 and the effects of different mitigation strategies, which researchers say could help guide new policies to combat the pandemic.
The first COVID-19 vaccines are here, but challenges remain
Whilst vaccines against COVID-19 show there is light at the end of the tunnel, three main challenges still need to be addressed.
A new biosensor detects COVID-19 antibodies in 10-12 seconds
The testing platform identifies the presence of two antibodies in microliter samples of blood.
Oxford–AstraZeneca COVID-19 vaccine shown to be safe and effective
The results of the company’s COVID-19 vaccine clinical trials are the first to be published in a peer-reviewed journal.
Moderna’s COVID-19 vaccine shows 95% efficacy
US company second to report impressive efficacy for its COVID-19 vaccine candidate.
Trial COVID-19 vaccine shown to be 90% effective
Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from Phase 3 study.
New test captures elusive blood biomarker to help identify severe COVID-19 before symptom onset
An inventive new approach lowers the limit of detection for a common assay, allowing researchers to identify elusive biomarkers in complex fluids, like the blood.
Precaution: A lesson from COVID-19
Measures that could have been taken at the beginning of the pandemic were not implemented as precautionary preparation but rather as reactionary to an already spreading virus, making it hard to contain.